RBRolf Becker

Rolf Becker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rolf Becker has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Consanguinity and pregnancy outcomes in a multi-ethnic, metropolitan European population

    by Rolf Becker, Thomas Keller, Rolf-Dieter Wegner, Heidemarie Neitzel, Markus Stumm, Ute Knoll, Markus Stärk, Heiner Fangerau, Alan Bittles


  • Open Access

    Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects

    by Rolf Becker, Thomas Keller, Holger Kiesewetter, Heiner Fangerau, Uta Bittner

    To identify patients at very high risk for adverse pregnancy outcome (APO) at the 20- to 23-week scan and to assess the effectiveness of Aspirin (ASS) and low molecular weight heparin (LMWH) starting after this examination.


  • ‘Normal’ nuchal translucency: a justification to refrain from detailed scan? Analysis of 6858 cases with special reference to ethical aspects

    by Rolf Becker, Lothar Schmitz, Stefania Kilavuz, Markus Stumm, Rolf‐Dieter Wegner, Uta Bittner

    Objective: To assess the prevalence and detection rate of major anomalies (MAs) by applying first trimester anomaly scan (FTAS) including first trimester fetal echocardiography (FTFE) to all fetuses and discuss ethical implications.Methods: The study group included 6879 consecutive fetuses with known outcome of pregnancy (follow‐up: 98%), 6565 with ‘normal’ nuchal translucency (NT) (≤P95), 314 with ‘increased’ NT (>P95). All fetuses received FTAS/FTFE. As MAs with the potential of being detected at FTAS/FTFE, we defined anomalies present at conception or developed during first trimester.Results: Prevalence of MAs in fetuses with ‘normal’ NT reached 1.7%. Although 29.8% of chromosomal abnormalities were found in the group of ‘normal’ NT, 77% of MAs accompanied by a normal karyotype were found in this group. In fetuses with ‘normal’ NT and MA, diagnosis was made prenatally in 87.4% (FTAS/FTFE: 58.6%).Conclusion: A relevant number of MA is present in fetuses with ‘normal’ NT. More than half will be detected by FTAS/FTFE. As consequence, one should discuss a concept in which also in fetuses with ‘normal’ NT, FTAS/FTFE should be offered. This concept can also be justified from an ethical point of view, which focuses on the principles of nonmaleficence, justice and respect for autonomy of the pregnant woman. © 2012 John Wiley & Sons, Ltd.


  • Identification of high-risk patients for adverse pregnancy outcome based on multivariate logistic regression analysis at 20–23 gestational weeks

    by Rolf Becker

    To establish and test a multivariate approach for identification of patients with high risk for adverse pregnancy outcome (APO) by a combination of sonographic (20+0-23+6 weeks) and biometrical data in a test group and to prove its effectiveness in a validation group. In order to develop a multivariate approach for identifying patients at high risk for APO, data from 15,855 non-treated singleton pregnancies (test group A), with well-known outcomes, were analysed retrospectively. Registered parameters were parity, body mass index (BMI), mean of pulsatility index of both uterine arteries (meanPI), presence of notch, and depth of notch described as the mean of the notch index of both uterine arteries (meanNI). In a second step, the model was validated in 3678 subsequent non-treated singleton pregnancies (validation group B). In test group A, the calculated probabilities of APO were found between 1.3% and 82.8%, with the 95th centile at 11.2% and the 99th centile at 28.3%. In validation group B, in patients with a low calculated risk for APO 28%, complications were found in 39.1%. A multivariate approach toward risk-assessment of APO seems to be a promising method for identifying patients who are at high risk for APO. Besides the individual consequence of intensive surveillance, the identification of groups of patients at high risk for APO might serve as a basis for interventional studies.


  • First-Trimester Prenatal Diagnosis of Okihiro Syndrome

    by R. Becker, D. Horn, U. Knoll, M. Stumm, R.D. Wegner, H. Peters, N. Sarioglu

    A case of Okihiro syndrome (OS) detected by 2- and confirmed by 3-dimensional ultrasound at 13+2 gestational weeks is reported. While the pregnant woman affected by the OS presented with limb anomalies, the fetus showed severe thoracoabdominal and skeletal anomalies. Termination of pregnancy was performed at 14+1 gestational weeks and confirmed the sonographically detected symptoms. The diagnosis was confirmed by autoptic, radiologic and molecular genetic analysis. To our knowledge, this is the first case of prenatal diagnosis of OS.


  • Doppler Sonography of Uterine Arteries at 20–23 Weeks: Depth of Notch Gives Information on Probability of Adverse Pregnancy Outcome and Degree of Fetal Growth Restriction in a Low-Risk Population

    by Rolf Becker, Richard Vonk

    Objective: Our purpose was to assess the relation between the depth of notch in the uterine arteries at 20–23 weeks and the incidence and severity of subsequent pregnancy complications. Methods: The Notch Index (NI) was defined as (C – D)/C, with C = postsystolic zenith and D = postsystolic nadir. For evaluation, the mean NI of the two uterine arteries was determined. Adverse pregnancy outcome was defined as presence of SGA ≤5th percentile, pre-eclampsia, preterm delivery <33 weeks, placental abruption or intrauterine or neonatal death. Women who received preventive treatment (Aspirin or low-molecular heparin) were excluded. Results: A notch was present in 957 of 15,888 singleton pregnancies (6.0%; unilateral = 4.37%, bilateral = 1.66%). The incidence of adverse pregnancy outcome was 5.3%; it increased from 4.6% for women without notch to 41.8% for those with a mean NI ≧0.2 and higher. Moreover, higher mean NI values tended to be associated with lower birth weight. In addition to the maternal age, parity, mean Pulsatility Index and presence of notch, the depth of notch made an additional significant contribution to the assessment of the probability of adverse pregnancy outcome. Conclusion: Besides the classic parameters such as maternal age, history of adverse pregnancy outcome, parity, impedance and the presence of notch, also the depth of notch seems to be valuable in the assessment of adverse pregnancy outcome risk. Especially in cases where very high or very low values of NI are measured, quantification of the depth of notch may give more information than the description of the presence of notch alone. This might be of value for future multivariate models for risk assessment of adverse pregnancy outcome.


  • Detailed screening for fetal anomalies and cardiac defects at the 11–13‐week scan

    by R. Becker, R.‐D. Wegner

    Objective: To assess the diagnostic efficacy of the first‐trimester anomaly scan including first‐trimester fetal echocardiography as a screening procedure in a ‘medium‐risk’ population.Methods: In a prospective study, we evaluated 3094 consecutive fetuses with a crown–rump length (CRL) of 45–84 mm and gestational age between 11 + 0 and 13 + 6 weeks, using transabdominal and transvaginal ultrasonography. The majority of patients were referred without prior abnormal scan or increased nuchal translucency (NT) thickness, the median maternal age was, however, 35 (range, 15–46) years, and 53.8% of the mothers (1580/2936) were 35 years or older. This was therefore a self‐selected population reflecting an increased percentage of older mothers opting for prenatal diagnosis. The follow‐up rate was 92.7% (3117/3363).Results: The prevalence of major abnormalities in 3094 fetuses was 2.8% (86/3094). The detection rate of major anomalies at the 11 + 0 to 13 + 6‐week scan was 83.7% (72/86), 51.9% (14/27) for NT < 2.5 mm and 98.3% (58/59) for NT ≥ 2.5 mm. The prevalence of major congenital heart defects (CHD) was 1.2% (38/3094). The detection rate of major CHD at the 11 to 13 + 6‐week scan was 84.2% (32/38), 37.5% (3/8) for NT < 2.5 mm and 96.7% (29/30) for NT ≥ 2.5 mm.Conclusion: The overall detection rate of fetal anomalies including fetal cardiac defects following a specialist scan at 11 + 0 to 13 + 6 weeks' gestation is about 84% and is increased when NT ≥ 2.5 mm. This extends the possibilities of a first‐trimester scan beyond risk assessment for fetal chromosomal defects. In experienced hands with adequate equipment, the majority of severe malformations as well as major CHD may be detected at the end of the first trimester, which offers parents the option of deciding early in pregnancy how to deal with fetuses affected by genetic or structural abnormalities without pressure of time. Copyright © 2006 ISUOG. Published by John Wiley & Sons, Ltd.


  • Open Access

    Autosomal recessive type of Adams–Oliver syndrome: prenatal diagnosis

    by R. Becker, J. Kunze, D. Horn, A. Gasiorek‐Wiens, M. Entezami, R. Rossi, M. Guschmann, N. Sarioglu

    We report on three pregnancies complicated by Adams–Oliver syndrome in a consanguineous Turkish couple. Two cases were correctly diagnosed prenatally at 22+3 and 13+0 weeks gestation following the first case of Adams–Oliver syndrome in which severe anomalies of the extremities were observed at 26+5 weeks' gestation. In this first case, the diagnosis of Adams–Oliver syndrome was made following termination of pregnancy at 27+2 weeks' gestation. In all three cases, autopsy was performed. All fetuses showed anomalies of the extremities, aplasia cutis and symmetric defects of the skull, with bone being replaced by collagenous tissue. Although there have been numerous cases of the postnatal diagnosis of Adams–Oliver syndrome following termination of pregnancy, this is the first description of the prenatal diagnosis of this disorder. Copyright © 2002 International Society of Ultrasound in Obstetrics and Gynecology


    • 1 July 2002
      • Vol. 96, 409-12

    [Preimplantation versus prenatal diagnosis--practice of prenatal diagnosis].

    by Rolf Heinrich Becker

    Both invasive and non-invasive prenatal medicinal procedures are well accepted in Germany. The health care system offers each pregnant woman a total of three sonographic examinations. Most of these examinations turn up normal findings, leading to the pregnancy being continued without fear. In the case of anomalies being detected, the findings may be life-saving for the mother or the foetus or reduce the severity of a neonatal disease. When a severe anomaly or a situation that is incompatible with postnatal life is detected, the pregnant woman may decide not to go through with the pregnancy. The latter state of affairs is the reason for 2% of all terminations of pregnancies. One of the aims of modern prenatal medicine is to provide information about whether a situation is normal or abnormal as soon as possible ("early anomaly scan", "nuchal translucency diagnostics"). In view of this background it is difficult to understand why the very small number of women with a high risk of a recurrence of severe anomalies diagnosable by PGD is not given access to this method but is forced to terminate their pregnancies in the event of an anomaly during their second trimester.